Showing results (41-50 of 86) with videos related to
Sort By:
Pageof 9
Annals of the Academy of Medicine, Singapore|December 2, 2014
Assessment of the American Joint Committee on Cancer 7th edition staging for localised prostate cancer in Asia treated with external beam radiotherapyMeihua Wong, Connie Yip, Huihua Li, et al.Scientific Reports|May 10, 2017
Hydration effects on the efficacy of the Epidermal growth factor receptor kinase inhibitor afatinibSrinivasaraghavan Kannan, Mohan R Pradhan, Garima Tiwari, et al.Cancer Biology & Therapy|November 15, 2006
EGFR Intron 1 polymorphism in Asian Populations and its correlation with EGFR gene expression and amplification in breast tumor tissuesQingyu Zhou, Yin Bun Cheung, Srinivasa Rao Jada, et al.Cancer Chemotherapy and Pharmacology|June 1, 2012
Phase I pharmacokinetic study of chronomodulated dose-intensified combination of capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancerMohamad Farid, Balram Chowbay, Xiangai Chen, et al.Cancer Chemotherapy and Pharmacology|April 7, 2011
The effects of CYP3A4, CYP3A5, ABCB1, ABCC2, ABCG2 and SLCO1B3 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of docetaxel in nasopharyngeal carcinoma patientsSin-Chi Chew, Onkar Singh, Xiangai Chen, et al.Nature Nanotechnology|March 9, 2021
Extracellular vesicle drug occupancy enables real-time monitoring of targeted cancer therapySijun Pan, Yan Zhang, Auginia Natalia, et al.Cancer Letters|December 23, 2016
Metronomic chemotherapy: A relook at its basis and rationaleTanujaa Rajasekaran, Quan-Sing Ng, Daniel Shao-Weng Tan, et al.Pharmacogenomics|June 15, 2007
Novel SLC22A16 polymorphisms and influence on doxorubicin pharmacokinetics in Asian breast cancer patientsSuman Lal, Zee Wan Wong, Srinivasa Rao Jada, et al.Plos One|May 3, 2016
Phase I Study of Oral Vinorelbine in Combination with Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Using Two Different SchedulesNatalia Sutiman, Zhenxian Zhang, Eng Huat Tan, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2008
PXR pharmacogenetics: association of haplotypes with hepatic CYP3A4 and ABCB1 messenger RNA expression and doxorubicin clearance in Asian breast cancer patientsEdwin Sandanaraj, Suman Lal, Viknesvaran Selvarajan, et al.Pageof 9